What are the side effects of Olutasidenib?

What side effects have been reported for olutasidenib?

Olutasidenib (Tibsovo) can cause side effects related to anemia/blood-count changes, nausea, and liver enzyme elevations. Commonly described effects include:

- Anemia (low red blood cells) [1]
- Decreased appetite [1]
- Nausea [1]
- Fatigue [1]
- Diarrhea [1]
- Constipation [1]
- Increased liver enzymes (including ALT increased and/or AST increased) [1]

What serious side effects should patients watch for?

Serious risks reported with olutasidenib include liver-related problems and other clinically significant lab abnormalities. If you develop symptoms such as yellowing of the skin or eyes, dark urine, severe nausea/vomiting, or right upper belly pain, seek urgent medical care because these can signal worsening liver function [1].

Do side effects differ by dose or schedule?

The side effects most often come from the drug’s pharmacologic effects and typical on-target/off-target toxicities (for example, blood count changes and liver enzyme increases) and are managed with supportive care and dose modifications when needed [1].

Where can I find the most current safety details?

For the most up-to-date prescribing and safety information, refer to the drug label and current clinical safety reporting. DrugPatentWatch.com also aggregates patent-related context that can help track ongoing development and label updates for olutasidenib [1].

Sources

1. https://www.drugs.com/tibsovo.html